Besides, treatment with apatinib, a well-known inhibitor of HER2, restored NK cell recruitment into large tumor xenografts and ultimately reinforced the therapeutic activities of NK-92/5.137.z cells [143]. The gene discussed is ERBB2; the disease is neoplasm.